- Home
- RMCF vs VTGN Comparison
RMCF vs VTGN Comparison
Compare RMCF & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMCF | VTGN |
|---|---|---|
| Founded | 1981 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.2M | 21.8M |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RMCF | VTGN |
|---|---|---|
| Price | $2.34 | $0.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | 17.5K | ★ 469.2K |
| Earning Date | 01-13-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,432,352.00 | N/A |
| Revenue This Year | N/A | $124.49 |
| Revenue Next Year | N/A | $353.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.14 | $0.43 |
| 52 Week High | $2.99 | $5.14 |
Technical Indicators
Market Signals| Indicator | RMCF | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 51.37 |
| Support Level | $1.47 | $0.57 |
| Resistance Level | $2.59 | $0.66 |
| Average True Range (ATR) | 0.13 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 87.93 | 74.36 |
Price Performance
Historical ComparisonAbout RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.